Clinical study to investigate safety and efficacy on autologous tumor lysate-pulsed dendritic cells

Phase 1

• Conditions: Malignant Glioma

• Registration Number: JPRN-UMIN000001903
• Lead Sponsor: Osaka National Hospital, National Hospital Organization

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2009-05-01
• Study Completion: 2013-03-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 15

Inclusion Criteria

Not provided

Exclusion Criteria

1)Pulmonary fibrosis or interstitial pneumonia, or their history, or predisposition to them 2)Serious drug allergy 3)Positive for hepatitis B, C, HIV-1, 2, HTLV-1 or syphilis 4)Serious cardiac disease 5)Active autoimmune diseases 6)Other cancers 7)Uncontrollable infection 8)Pregnancy or lactation 9)Gelling of plasma, cryogloblinemia 10)Any reason why, in the opinion of the investigator, the patient should not participate

Study & Design

• Study Type: Interventional
• Study Design: Not specified